comparemela.com
Home
Live Updates
Christinel Espiritu - Breaking News
Pages:
Latest Breaking News On - Christinel espiritu - Page 1 : comparemela.com
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001.
Kalyan
Maharashtra
India
Canada
United-states
Canadian
Katie-anderson
Ram-bhamidimarri
Ronaldg-nahass
Deana-antoniello
Kosh-agarwal
Anita-kohli
Arbutus to Present AB-729 and AB-836 Data at EASL Congress
WARMINSTER, Pa., June 07, 2023 (GLOBE NEWSWIRE) Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging.
Canada
Vienna
Wien
Austria
United-states
Canadian
Fung-yuen
N-acetylgalactosamine-galnac
Lisam-caperelli
Christinel-espiritu
Securities-exchange
Arbutus-biopharma-corporation-nasdaq
vimarsana © 2020. All Rights Reserved.